ResQFoam for the Treatment of Non-Compressible Hemorrhage on the Front Line.
Noncompressible torso hemorrhage is the leading cause of potentially survivable death on the battlefield. While medical advances have decreased the rate of "died of wounds" to less than 5%, significant treatment limitations in pre-hospital care remain. To address this persistent capability gap, the Defense Advanced Research Projects Agency launched the Wound Stasis System program in 2010. Under that program, Arsenal Medical, in collaboration with Massachusetts General Hospital and Harvard Medical School, developed a novel, self-expanding polyurethane foam that rapidly treats major abdominal bleeding due to trauma, for use at the point of care. This foam treatment is envisioned as an emergency "bridge to surgery" for warfighters who would otherwise die in the field. This commentary presents this emerging technology with the objective to bring to the community's attention a potentially promising device for the treatment of noncompressible abdominal hemorrhage.
Strategic Analysis, Inc., 4075 Wilson Boulevard, Suite 200, Arlington, VA 22203.
Julius C
JC
Chang
Office of Naval Research Global, 86 Blenheim Crescent, Unit 4540, Ruislip, Middlesex HA4 7HB, United Kingdom.
Brian C
BC
Holloway
Science and Technology Associates, Inc., 4100 N. Fairfax Drive, Suite 910, Arlington, VA 22203.
Monica
M
Zamisch
Biological Technologies Office, Defense Advanced Research Projects Agency, 675 N. Randolph St. Arlington, VA 22203.
Matthew J
MJ
Hepburn
Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814.
Geoffrey S F
GS
Ling
D000007:Abdominal Injuries / Q000150:complications*; D000818:Animals; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006489:Hemostatic Techniques; D008887:Military Medicine; D011140:Polyurethanes / Q000627:therapeutic use*; D013552:Swine; D000067398:War-Related Injuries / Q000150:complications
D011140:Polyurethanes; C028279:polyurethane foam